Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 321

Similar articles for PubMed (Select 22225906)

1.
2.

Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression.

Lee J, Condello S, Yakubov B, Emerson R, Caperell-Grant A, Hitomi K, Xie J, Matei D.

Clin Cancer Res. 2015 Jun 3. pii: clincanres.0226.2015. [Epub ahead of print]

PMID:
26041746
3.

An unprecedented dual antagonist and agonist of human Transglutaminase 2.

Yi MC, Palanski BA, Quintero SA, Plugis NM, Khosla C.

Bioorg Med Chem Lett. 2015 May 15. pii: S0960-894X(15)00456-4. doi: 10.1016/j.bmcl.2015.05.006. [Epub ahead of print]

PMID:
26004580
4.

Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.

Fisher ML, Adhikary G, Xu W, Kerr C, Keillor JW, Eckert RL.

Oncotarget. 2015 May 8. [Epub ahead of print]

5.
6.

Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.

Fisher ML, Keillor JW, Xu W, Eckert RL, Kerr C.

Mol Cancer Res. 2015 May 1. [Epub ahead of print]

PMID:
25934691
7.

Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor.

Liu Y, Chen C, Qian P, Lu X, Sun B, Zhang X, Wang L, Gao X, Li H, Chen Z, Tang J, Zhang W, Dong J, Bai R, Lobie PE, Wu Q, Liu S, Zhang H, Zhao F, Wicha MS, Zhu T, Zhao Y.

Nat Commun. 2015 Jan 23;6:5988. doi: 10.1038/ncomms6988.

8.

Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.

Bogachek MV, De Andrade JP, Weigel RJ.

Cancer Res. 2015 Jan 1;75(1):11-5. doi: 10.1158/0008-5472.CAN-14-2824. Epub 2014 Dec 18. Review.

PMID:
25524900
9.

PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.

Meng F, Speyer CL, Zhang B, Zhao Y, Chen W, Gorski DH, Miller FR, Wu G.

Cancer Res. 2015 Feb 1;75(3):584-93. doi: 10.1158/0008-5472.CAN-13-3029. Epub 2014 Dec 10.

10.

Reinforcing targeted therapeutics with phenotypic stability factors.

Yaswen P.

Cell Cycle. 2014;13(24):3818-22. doi: 10.4161/15384101.2014.985071.

PMID:
25483053
11.

Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.

Nadella V, Wang Z, Johnson TS, Griffin M, Devitt A.

Biochim Biophys Acta. 2015 Jan;1853(1):201-12. doi: 10.1016/j.bbamcr.2014.09.020. Epub 2014 Oct 29.

PMID:
25449226
12.

Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.

Wamsley JJ, Kumar M, Allison DF, Clift SH, Holzknecht CM, Szymura SJ, Hoang SA, Xu X, Moskaluk CA, Jones DR, Bekiranov S, Mayo MW.

Cancer Res. 2015 Jan 15;75(2):426-35. doi: 10.1158/0008-5472.CAN-13-2702. Epub 2014 Nov 28.

PMID:
25432175
13.
14.

Cancer stem cells of the digestive system.

Colvin HS, Nishida N, Koseki J, Konno M, Kawamoto K, Tsunekuni K, Doki Y, Mori M, Ishii H.

Jpn J Clin Oncol. 2014 Dec;44(12):1141-9. doi: 10.1093/jjco/hyu146. Epub 2014 Oct 1. Review.

15.

Transglutaminase 2 and neuroinflammation.

Ientile R, Currò M, Caccamo D.

Amino Acids. 2015 Jan;47(1):19-26. doi: 10.1007/s00726-014-1864-2. Epub 2014 Nov 15.

PMID:
25398223
16.

Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state.

Katz Y, Li F, Lambert NJ, Sokol ES, Tam WL, Cheng AW, Airoldi EM, Lengner CJ, Gupta PB, Yu Z, Jaenisch R, Burge CB.

Elife. 2014 Nov 7;3:e03915. doi: 10.7554/eLife.03915.

17.

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.

Lu H, Clauser KR, Tam WL, Fröse J, Ye X, Eaton EN, Reinhardt F, Donnenberg VS, Bhargava R, Carr SA, Weinberg RA.

Nat Cell Biol. 2014 Nov;16(11):1105-17. doi: 10.1038/ncb3041. Epub 2014 Sep 28.

18.

Breast cancer stem cells, EMT and therapeutic targets.

Kotiyal S, Bhattacharya S.

Biochem Biophys Res Commun. 2014 Oct 10;453(1):112-6. doi: 10.1016/j.bbrc.2014.09.069. Epub 2014 Sep 26. Review.

PMID:
25261721
19.
20.

Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.

Ashour AA, Gurbuz N, Alpay SN, Abdel-Aziz AA, Mansour AM, Huo L, Ozpolat B.

J Cell Mol Med. 2014 Nov;18(11):2235-51. doi: 10.1111/jcmm.12361. Epub 2014 Sep 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk